Monetary Solutions’s Genmab GMAB Stock Holding History

Monetary Solutions’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275	Buy	+10	New	+$266	﹤0.01%	363

Other funds holding GMAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Monetary Solutions's GMAB Position: Q2 2026 in Review

Monetary Solutions opened a new position in Genmab (GMAB) in Q2 2026: 10 shares worth $275. The stake represents ﹤0.01% of the portfolio and ranks #363 among its holdings.

210 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Monetary Solutions held 10 shares of Genmab worth $275 as of Q2 2026.
Genmab was a new Monetary Solutions position in Q2 2026.
Genmab made up ﹤0.01% of Monetary Solutions's portfolio in Q2 2026, its #363 holding.
210 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Monetary Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.